When biotech goes bad

Journal name:
Nature Biotechnology
Volume:
34,
Pages:
284–291
Year published:
DOI:
doi:10.1038/nbt.3510
Published online
Corrected online

A look at 20 years of the dark side of biotech.

Change history

Corrected online 31 March 2016
In the version of this article initially published, on p.286, in the timeline, far right, “2008 Intercept” should have read “2008 InterMune.” The error has been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

  1. John Hodgson is Data Editor, Pharma at Informa Business Information, London, UK, and Editor-at-Large, Nature Biotechnology.

Corresponding author

Correspondence to:

Author details

Additional data